BN44083
A Study to Investigate the Safety, Tolerability, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of Ascending Intravenous Doses of Glofitamab, Administered after Ocrelizumab Pretreatment, in Patients with Multiple Sclerosis
What it found
No result found
We found no results in the registry or in papers.
Loading reviews and guidelines…
History
Started
Jul 2023
Finished
Jan 2026
Assembled by software from public sources and not checked by people. Each record links to its source. Report an error